The Marked Chart Wire · Health
Zai Lab
Zai Lab secures coverage for five drugs in China
Zai Lab Limited confirmed that five of its commercial treatments, including KarXT and VYVGART Hytrulo, are now part of the national reimbursement program for 2026.
